Neuro AS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 65,701 | 70,576 | 75,992 | 107,629 | 75,620 | 74,377 | 82,859 | 82,252 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 4,890 | 7,563 | 8,863 | 25,204 | 9,085 | 8,834 | 13,413 | 28,751 |
| Equity | 53,595 | 61,158 | 83,814 | 109,017 | 24,413 | 37,456 | 50,870 | 50,209 |
| Liabilities | 11,559 | 4,128 | 682 | 1,541 | 955 | 868 | 1,123 | 1,877 |
| Non-current assets | 48,830 | 41,271 | 33,866 | 9,205 | 3,471 | 1,454 | 1,023 | 1,136 |
| Current assets | 7,182 | 5,382 | 5,078 | 11,001 | 7,327 | 1,177 | 1,350 | 5,934 |
| Total assets | 56,012 | 46,653 | 38,944 | 20,206 | 10,798 | 2,631 | 2,373 | 7,070 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 8,920 | 10,762 | 12,472 |
| Social insurance contributions | - | - | - | - | - | 9,349 | 11,341 | 2,466 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +10.6% | +7.4% | +7.7% | +41.6% | -29.7% | -1.6% | +11.4% | -0.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.7% | 16.2% | 22.8% | 124.7% | 84.1% | 335.8% | 565.2% | 406.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 9.1% | 12.4% | 10.6% | 23.1% | 37.2% | 23.6% | 26.4% | 57.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.4% | 10.7% | 11.7% | 23.4% | 12.0% | 11.9% | 16.2% | 35.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 10,950 | 11,763 | 12,665 | 17,938 | 12,603 | 14,875 | 14,204 | 24,074 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Neuro AS - Social security debts
The company had no debts to Sodra
Neuro AS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-17 | 2025-06-05 | 5.95 |
| 2024-11-17 | 2024-11-29 | 0.19 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Neuro AS, UAB (code 166911019) is a Private Limited Liability Company active in medical specialists activities. In 2025, the company generated €82.3K in revenue, broadly in line with €82.9K in 2024 and above €74.4K in 2023. Net profit improved more strongly, rising from €8.8K in 2023 to €13.4K in 2024 and €28.8K in 2025, which lifted the 2025 profit margin to 35.0%. Revenue growth in 2025 was slightly negative at -0.7% year on year, while the two-year revenue change remained positive at 10.6%, indicating a stable top line with stronger profitability. The 2025 balance sheet remained small, with total assets of €7.1K, equity of €50.2K and liabilities of €1.9K. Revenue per employee reached €27.4K, while profit per employee was €9.6K. Overall, the latest year shows flat revenue but a marked improvement in earnings.